資料載入處理中...
臺灣人文及社會科學引文索引資料庫系統
:::
網站導覽
國圖首頁
聯絡我們
操作說明
English
行動版
(18.217.128.94)
登入
字型:
**字體大小變更功能,需開啟瀏覽器的JAVASCRIPT,如您的瀏覽器不支援,
IE6請利用鍵盤按住ALT鍵 + V → X → (G)最大(L)較大(M)中(S)較小(A)小,來選擇適合您的文字大小,
如為IE7以上、Firefoxy或Chrome瀏覽器則可利用鍵盤 Ctrl + (+)放大 (-)縮小來改變字型大小。
來源文獻查詢
引文查詢
瀏覽查詢
作者權威檔
引用/點閱統計
我的研究室
資料庫說明
相關網站
來源文獻查詢
/
簡易查詢
/
查詢結果列表
/
詳目列表
:::
詳目顯示
第 1 筆 / 總合 1 筆
/1
頁
來源文獻資料
摘要
外文摘要
引文資料
題名:
腫瘤標記的臨床應用與發展
書刊名:
臺灣公共衛生雜誌
作者:
陳星佑
/
吳岱穎
/
鄭企峰
/
郭冠良
/
陳建志
作者(外文):
Chen, Hsing-yu
/
Wu, Tai-yin
/
Cheng, Chi-fen
/
Kuo, Kuan-liang
/
Chen, Chien-chih
出版日期:
2014
卷期:
33:4
頁次:
頁352-359
主題關鍵詞:
腫瘤標記
;
惡性腫瘤
;
篩檢
;
診斷
;
Tumor marker
;
Malignancy
;
Screening
;
Diagnosis
原始連結:
連回原系統網址
相關次數:
被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
排除自我引用:0
共同引用:0
點閱:8
在健檢風行的今日台灣,腫瘤標記常常是各類健康檢查的熱門項目之一。惟腫瘤標記所代表的意義,多數民眾僅是一知半解。本文旨在報導近期腫瘤標記之臨床應用與發展。我們搜尋了2003至2013十年間的腫瘤標記相關回顧文獻並加以評讀、整理,依序介紹肺癌、肝癌、大腸直腸癌、乳癌、攝護腺癌、胰臟癌、卵巢癌與其對應的腫瘤標記之定義與分類,特性與臨床上之角色。本文也報導近期研究中發展之新興腫瘤標記,雖然近一、二十年來新興腫瘤標記蓬勃發展,都仍無法取代目前常用之標記如甲型胎兒蛋白、癌抗原125(CA 125)等。且新興腫瘤標記在早期發現與診斷之應用相對局限,所以未來仍需要實驗室與臨床密切配合,追尋可廣為應用之標記來提升癌症之防治。同時,公衛領域人員在解釋這些腫瘤標記的意義時應小心謹慎,不宜過度解讀或依賴腫瘤標記。
以文找文
Periodic health examinations are common practice in Taiwan. Tumor markers are popular laboratory tests which are ordered as part of a health check-up; however, the significance of tumor markers is only partially understood by people. The purpose of this article was to report recent clinical developments and applications of tumor markers. We searched and studied relevant review articles about tumor markers published in the 10 years between 2003 and 2013. We present the definition, classification, characteristics, and clinical roles of tumor markers corresponding to lung, hepatic, colorectal, breast, prostatic, pancreatic, and ovarian cancers. We also report newly developed tumor markers. Although novel tumor markers have flourished in the recent 10-20 years, novel tumor markers cannot replace the well-established tumor markers, such as α-fetoprotein and cancer antigen 125. Studies focusing on the application of novel tumor markers in early disease detection and diagnosis are limited. There is still a need for close collaboration between bench and bedside to search for more widely applicable markers and to improve cancer prevention. Thus, public health workers should exercise caution in explaining the meaning of these tumor markers and avoid over-interpretation or over-reliance on novel tumor markers.
以文找文
期刊論文
1.
Nair, R. R.、Johnson, J. K.(2008)。A dictionary to tumor markers and the methods of estimation。Advanced BioTech,7,22-32。
2.
Zheng, W.、McLerran, D. F.、Rolland, B. A.(2014)。Burden of total and cause-specific mortality related to tobacco smoking among adults aged >45 years in Asia: a pooled analysis of 21 cohorts。PLoS Med,11,1001631。
3.
Yang, S. C.、Lai, W. W.、Su, W. C.(2013)。Estimating the lifelong health impact and financial burdens of different types of lung cancer。BMC Cancer,13,579。
4.
Witjes, C. D.、Steyerberg, E. W.(2013)。Recently introduced biomarkers for screening of hepatocellular carcinoma: a systemic review and meta-analysis。Hepatol Int,7,59-64。
5.
Chen, C. J.、Hsu, W. L.、Yang, H. I.(2014)。Epidemiology of virus infection and human cancer。Recent Results Cancer Res,193,11-32。
6.
Makarem, M.(2012)。An overview of biomarkers for the diagnosis of hepatocellular carcinoma。Hepat Mon,12,6122。
7.
Perkins, G. L.、Slater, E. D.、Sanders, G. K.、Prichard, J. G.(2003)。Serum tumor markers。Am Fam Physician,68,1075-1082。
8.
Lee, Y. C.、Lee, Y. L.、Chuang, J. P.、Lee, J. C.(2013)。Differences in survival between colon and rectal cancer from SEER data。PLoS One,8,78709。
9.
Vaidyanathan, K.、Vasudevan, D. M.(2012)。Organ specific tumor markers: what’s new?。Indian J Clin Biochem,27,110-120。
10.
Lin, C. H.、Chuang, P. Y.、Chiang, C. J.(2014)。Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an East Asian country: a nationwide cancer registry-based study。Oncologist,19,583-591。
11.
Duffy, M. J.、Evoy, D.、McDermott, E. W.(2010)。CA 15-3: uses and limitation as a biomarker for breast cancer。Clin Chim Acta,411,1869-1874。
12.
Basch, E.、Oliver, T. K.、Vickers, A.(2012)。Screening for prostate cancer with prostatic-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion。J Clin Oncol,30,3020-3025。
13.
Shariat, S. F.、Semjonow, A.、Lilja, H.、Savage, C.、Vickers A.、Bjartell A.(2011)。Tumor markers in prostate cancer I: blood-based markers。Acta Oncol,50,61-75。
14.
Lee, Y. J.、Park, J. E.、Jeon, B. R.、Lee, S. M.、Kim, S. Y.、Lee, Y. K.(2013)。Is prostate-specific antigen effective for population screening of prostate cancer? A systematic review。Ann Lab Med,33,233-241。
15.
Thompson, I. M.、Pauler, D. K.、Goodman, P. J.(2004)。Prevalence of prostate cancer among men with a prostate-specific antigen level < 4.0 ng per milliliter。N Engl J Med,350,2239-2246。
16.
Broadberry, R. E.(1991)。The Lewis blood group system among Chinese in Taiwan。Hum Hered,41,290-294。
17.
Duffy, M. J.、Bonfrer, J. M.、Kulpa, J.(2005)。CA 125 in ovarian cancer: European group on tumor markers guidelines for clinical use。Int J Gynecol Cancer,15,679-691。
18.
Ba, M. C.、Long, H.、Tang, Y. Q.、Cui, S. Z.(2012)。GP73 expression and its significance in the diagnosis of hepatocellular carcinoma: a review。Int J Clin Exp Pathol,5,874-881。
19.
Ganepola, G. A.、Nizin, J.、Rutledge, J. R.、Chang, D. H.(2014)。Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer。World J Gastrointest Oncol,6,83-97。
20.
Yan, Z.、Wei, C.、Luo, Z.、Li L.(2013)。Clinical value of serum human epididymis protein 4 assay in the diagnosis of ovarian cancer: a meta-analysis。Onco Targets Ther,6,957-966。
21.
Ferraro, S.、Braga, F.、Lanzoni, M.(2013)。Serum human epididymis protein 4 versus carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review。J Clin Pathol,66,273-281。
22.
Filella, X.、Gimenez, N.(2013)。Evaluation of [-2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta¬analysis。Clin Chem Lab Med,51,729-739。
其他
1.
衛生福利部統計處。2012年死因統計年報與死因結果摘要表,http://www.mohw.gov.tw/cht/DOS/Statistic.aspx?f_list_no=312&fod_list_no=2747, 2013/08/31。
延伸查詢
2.
European Group on Tumor Markers。Guidelines,http://egtm.eu/recommendations.html, 2013/09/21。
3.
National Comprehensive Cancer Network。Guidelines,http://www.nccn.org/professionals/physiciangls/f-guidelines.asp., 2013/09/21。
推文
當script無法執行時可按︰
推文
推薦
當script無法執行時可按︰
推薦
引用網址
當script無法執行時可按︰
引用網址
引用嵌入語法
當script無法執行時可按︰
引用嵌入語法
轉寄
當script無法執行時可按︰
轉寄
top
:::
相關期刊
相關論文
相關專書
相關著作
熱門點閱
1.
自閉症嬰幼兒的早期診斷:文獻回顧
無相關博士論文
無相關書籍
無相關著作
1.
憤怒羅曼史:異性戀女性向戀愛模擬遊戲中的性/性別權力
2.
戲癮:臺灣小劇場剖面
3.
遲來的後殖民 : 賴香吟解嚴小說中的知識菁英和底層人民
4.
臺灣自行車產業--從合作生產到合作創新
5.
臺日漁業協議之現時評析與臺菲漁業談判之未來展望
6.
轉換型領導與部屬工作績效:探討部屬適配知覺的中介效果及部屬適應性特質的干擾效果
7.
鴉片戰爭前澳門葡人財政演變及其特徵
8.
澳門的假釋模式:監獄建議的定量分析
9.
澳門人口承載力的若干問題
10.
變焦的注意力:探索顯著共線物體阻撓搜尋的原因
11.
應用產品創新設計技術以提昇產業經營競爭力
12.
校園路跑運動參與程度感受對睡眠品質之比較研究
13.
以魔幻展現鄉土與自我困惑--童偉格〈王考〉釋詮
14.
調暢情深--論張若虛〈春江花月夜〉在明代的接受
15.
臺灣制憲運動的回顧與展望--以民主進步黨為中心
QR Code